129 related articles for article (PubMed ID: 8746073)
41. The effect of intranasal salmon calcitonin on biochemical parameters of bone turnover in postmenopausal women.
Balint-Perić LA; Prelević GM; Beslagić Z; Petrović J
Gynecol Endocrinol; 1994 Dec; 8(4):241-5. PubMed ID: 7709763
[TBL] [Abstract][Full Text] [Related]
42. Effects of cyclic therapy with intranasal carbocalcitonin in healthy spontaneous postmenopausal women.
De Aloysio D; Pansini F; Campobasso C; Zanotti L; Abbruzzese AD; Mauloni M; Bottiglioni F
Clin Exp Obstet Gynecol; 1996; 23(2):87-93. PubMed ID: 8737620
[TBL] [Abstract][Full Text] [Related]
43. [Comparative study of the in vitro effects of calcitonin, NaF and ipriflavone in cell culture].
Bucsi L; Ashton BA
Magy Traumatol Ortop Kezseb Plasztikai Seb; 1994; 37(3):257-60. PubMed ID: 7920911
[TBL] [Abstract][Full Text] [Related]
44. Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.
Gennari C; Agnusdei D; Camporeale A
Osteoporos Int; 1993; 3 Suppl 1():208-10. PubMed ID: 8461563
[No Abstract] [Full Text] [Related]
45. Calcitonin load test to assess the efficacy of salmon calcitonin.
Stepan JJ; Zikán V
Clin Chim Acta; 2003 Oct; 336(1-2):49-55. PubMed ID: 14500034
[TBL] [Abstract][Full Text] [Related]
46. Metabolic changes in bone in old age.
Pratelli L; Ravaglia G; Ciapetti G; Pizzoferrato A
Ital J Orthop Traumatol; 1992; 18(1):95-105. PubMed ID: 1399540
[TBL] [Abstract][Full Text] [Related]
47. Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females.
Nakamura S; Morimoto S; Takamoto S; Onishi T; Fukuo K; Koh E; Kitano S; Miyashita Y; Yasuda O; Tamatani M
Calcif Tissue Int; 1992; 51 Suppl 1():S30-4. PubMed ID: 1422983
[TBL] [Abstract][Full Text] [Related]
48. [Randomized comparative study using carbocalcitonin i.m. vs carbocalcitonin nasal spray vs ipriflavone x os in the treatment of post-menopausal osteoporosis].
Lobianco R; Merola B; Lupoli G; Cocca A; Guarino M; Pia M; Guerriero S; Lombardi G
Minerva Endocrinol; 1992; 17(2):79-84. PubMed ID: 1296148
[TBL] [Abstract][Full Text] [Related]
49. A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium.
Reginster JY; Meurmans L; Deroisy R; Jupsin I; Biquet I; Albert A; Franchimont P
Eur J Clin Invest; 1994 Aug; 24(8):565-9. PubMed ID: 7982445
[TBL] [Abstract][Full Text] [Related]
50. Intranasal salmon calcitonin in postmenopausal osteoporosis: effect of different therapeutic regimens on vertebral and peripheral bone density.
Perrone G; Galoppi P; Valente M; Capri O; D'Ubaldo C; Anelli G; Zichella L
Gynecol Obstet Invest; 1992; 33(3):168-71. PubMed ID: 1612530
[TBL] [Abstract][Full Text] [Related]
51. [Postmenopausal osteoporosis treated with acupoint injection of salmon calcitonin:a randomized controlled trial].
Zhou Z; Wang N; Ding C; Zhou X; Zhou J
Zhongguo Zhen Jiu; 2016 Jul; 36(7):705-708. PubMed ID: 29231409
[TBL] [Abstract][Full Text] [Related]
52. Effect of ipriflavone on bone mass in elderly osteoporotic women.
Passeri M; Biondi M; Costi D; Bufalino L; Castiglione GN; Di Peppe C; Abate G
Bone Miner; 1992 Oct; 19 Suppl 1():S57-62. PubMed ID: 1422322
[TBL] [Abstract][Full Text] [Related]
53. Effects of ipriflavone on bone loss following a bilateral ovariectomy and menopause: a randomized placebo-controlled study.
Katase K; Kato T; Hirai Y; Hasumi K; Chen JT
Calcif Tissue Int; 2001 Aug; 69(2):73-7. PubMed ID: 11683426
[TBL] [Abstract][Full Text] [Related]
54. Effects of nasal administration of calcitonin in oophorectomized women: 2-year controlled double-blind study.
Grigoriou O; Papoulias I; Vitoratos N; Papadias C; Konidaris S; Antoniou G; Chryssikopoulos A
Maturitas; 1997 Dec; 28(2):147-51. PubMed ID: 9522322
[TBL] [Abstract][Full Text] [Related]
55. Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation.
Reginster JY; Gaspar S; Deroisy R; Zegels B; Franchimont P
Osteoporos Int; 1993 Sep; 3(5):261-4. PubMed ID: 8400608
[TBL] [Abstract][Full Text] [Related]
56. Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women.
Fioretti P; Gambacciani M; Taponeco F; Melis GB; Capelli N; Spinetti A
Maturitas; 1992 Dec; 15(3):225-32. PubMed ID: 1465036
[TBL] [Abstract][Full Text] [Related]
57. Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.
Bandeira L; Lewiecki EM; Bilezikian JP
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):681-9. PubMed ID: 27070719
[TBL] [Abstract][Full Text] [Related]
58. Effects of salmon calcitonin suppositories in the prevention of bone loss in oophorectomized women.
Polatti F; Perotti F; Angelini GP; Vassellatti D; Rapisardi I
Maturitas; 1993 Dec; 18(1):73-6. PubMed ID: 8107619
[TBL] [Abstract][Full Text] [Related]
59. [Synthetic salmon calcitonin suppositories for the short-term treatment of involutive osteoporosis].
Isaia GC; Di Stefano M; Sciolla A; Mussetta M; Vassellatti D
Minerva Med; 1995 Mar; 86(3):101-4. PubMed ID: 7603605
[TBL] [Abstract][Full Text] [Related]
60. Effect of nasal salmon calcitonin on calcium and bone metabolism.
Thamsborg G
Dan Med Bull; 1999 Apr; 46(2):118-26. PubMed ID: 10327295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
